March 5, 2014

Merz North America on Tuesday announced the appointment of Gregory Bass as VP managed markets.

October 10, 2013

A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

April 5, 2013

Merz on Friday announced the introduction of new packaging for its Mederma Stretch Marks Therapy that "addresses major retail challenges."

February 4, 2013

Merz North America on Monday named Jim Hartman VP of the Merz Aesthetics business unit, which includes Xeomin, Radiesse and Belotero Balance.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

July 9, 2012

Merz has promoted one of its executives to serve as VP and chief compliance officer.